Bredt David

Rapport Therapeutics, Inc. Common Stock ยท Chief Scientific Officer

Bredt David is listed in public filings as officer: Chief Scientific Officer. This Bredt David insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Rapport Therapeutics, Inc. Common Stock (RAPP). Investors use Bredt David's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Rapport Therapeutics, Inc. Common StockRAPP$159k88.1k sharesGrant / ExerciseFeb 19, 2026$10.8K6k shares$1.80--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Rapport Therapeutics, Inc. Common StockRAPP$11M389.3k sharesSellFeb 17, 2026$156.3K5.4k shares$28.95--
Rapport Therapeutics, Inc. Common StockRAPP$11M387.1k sharesSellFeb 17, 2026$65.1K2.2k shares$29.59--
Rapport Therapeutics, Inc. Common StockRAPP$11M394.7k sharesSellFeb 17, 2026$25.2K900 shares$28.02--
Rapport Therapeutics, Inc. Common StockRAPP$2.9M103k sharesGrant / ExerciseFeb 2, 2026$2.9M103k shares$27.75--
Rapport Therapeutics, Inc. Common StockRAPP$11M395.8k sharesSellJan 15, 2026$222.7K8.3k shares$26.83--
Rapport Therapeutics, Inc. Common StockRAPP$11M395.6k sharesSellJan 15, 2026$5.5K200 shares$27.40--
Rapport Therapeutics, Inc. Common StockRAPP$12M404.1k sharesSellDec 31, 2025$197.3K6.6k shares$30.05--
Rapport Therapeutics, Inc. Common StockRAPP--410.6k sharesGrant / ExerciseDec 31, 2025Disclosure amount unavailable18k shares----
Rapport Therapeutics, Inc. Common StockRAPP$12M393.4k sharesSellDec 15, 2025$230.7K7.7k shares$29.95--
Rapport Therapeutics, Inc. Common StockRAPP$12M392.6k sharesSellDec 15, 2025$24.4K796 shares$30.68--
Rapport Therapeutics, Inc. Common StockRAPP$10M401.1k sharesSellNov 17, 2025$135.7K5.3k shares$25.39--
Rapport Therapeutics, Inc. Common StockRAPP$10M406.5k sharesSellNov 17, 2025$78.4K3.2k shares$24.84--
Rapport Therapeutics, Inc. Common StockRAPP$11M410.7k sharesSellOct 15, 2025$190.9K7.4k shares$25.73--
Rapport Therapeutics, Inc. Common StockRAPP$11M409.6k sharesSellOct 15, 2025$28.3K1.1k shares$26.16--
Rapport Therapeutics, Inc. Common StockRAPP$10M421.5k sharesSellSep 15, 2025$121.8K5.1k shares$23.88--
Rapport Therapeutics, Inc. Common StockRAPP$10M418.1k sharesSellSep 15, 2025$83.9K3.4k shares$24.66--
Rapport Therapeutics, Inc. Common StockRAPP$6.7M426.6k sharesSellAug 15, 2025$3.2K200 shares$15.79--
Rapport Therapeutics, Inc. Common StockRAPP$6.4M426.8k sharesSellAug 15, 2025$124.3K8.3k shares$14.98--
Rapport Therapeutics, Inc. Common StockRAPP$6.1M435.1k sharesSellJul 15, 2025$119.0K8.5k shares$14.00--
Rapport Therapeutics, Inc. Common StockRAPP$4.9M443.6k sharesSellJun 16, 2025$93.5K8.5k shares$11.00--
Rapport Therapeutics, Inc. Common StockRAPP$4.3M452.1k sharesSellMay 15, 2025$81.3K8.5k shares$9.56--
Rapport Therapeutics, Inc. Common StockRAPP$4.4M460.6k sharesSellApr 15, 2025$81.3K8.5k shares$9.57--
Rapport Therapeutics, Inc. Common StockRAPP$5.1M469.1k sharesSellMar 14, 2025$92.2K8.5k shares$10.85--
Rapport Therapeutics, Inc. Common StockRAPP$1.7M100k sharesGrant / ExerciseFeb 3, 2025$1.7M100k shares$16.60--